Advances in the treatment of primary brain tumors: Dawn of a new era?

被引：12

作者：

Gilbert M.R. ^{[1
]}

机构：

[1] Department of Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030

来源：

Current Oncology Reports | 2006年 / 8卷 / 1期

关键词：

Epidermal Growth Factor Receptor; Clin Oncol; Temozolomide; Malignant Glioma; Radiat Oncol Biol Phys;

D O I：

10.1007/s11912-006-0008-6

中图分类号：

学科分类号：

摘要：

The prognosis for patients with malignant primary brain tumors has been poor, and until recently, there was little evidence that chemotherapy was beneficial. The publication of the phase III trial comparing the combination of temozolomide with external beam radiation therapy with radiation therapy alone demonstrated a clear survival benefit for the combination regimen. These results, along with improvements in clinical trial design and outcome assessment, advances in our understanding of glioma tumor biology, and recognition of critical drug-drug interactions, have provided a foundation for developing better treatments for these cancers. Copyright © 2006 by Current Science Inc.

引用

页码：45 / 49

页数：4

共 43 条

[1]

Walker M.D., Alexander Jr. E., Hunt W.E., Et al., Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial, J Neurosurg, 49, pp. 333-343, (1978)

[2]

Walker M.D., Green S.B., Byar D.P., Et al., Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery, N Engl J Med, 303, pp. 1323-1329, (1980)

[3]

Fine H.A., Dear K.B., Loeffler J.S., Et al., Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults, Cancer, 71, pp. 2585-2597, (1993)

[4]

Stewart L.A., Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials, Lancet, 359, pp. 1011-1018, (2002)

[5]

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council trial, J Clin Oncol, 19, pp. 509-518, (2001)

[6]

Stupp R., Mason W.P., van den Bent M.J., Et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, pp. 987-996, (2005)

[7]

Macdonald D.R., Cascino T.L., Schold Jr. S.C., Cairncross J.G., Response criteria for phase II studies of supratentorial malignant glioma, J Clin Oncol, 8, pp. 1277-1280, (1990)

[8]

Sorensen A.G., Patel S., Harmath C., Et al., Comparison of diameter and perimeter methods for tumor volume calculation, J Clin Oncol, 19, pp. 551-557, (2001)

[9]

Warren K.E., Patronas N., Aikin A.A., Et al., Comparison of one-, two, and three-dimensional measurements of childhood brain tumors, J Natl Cancer Inst, 93, pp. 1401-1405, (2001)

[10]

Chen X., Tohme M., Park R., Et al., Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide, Mol Imaging, 3, pp. 96-104, (2004)

← 1 2 3 4 5 →